EMTRICITABINE

Emtricitabine [Cas No. 143491-57-0] is a nucleoside reverse transcriptase inhibitor [NRTI] API which is mostly used in treatment of antiviral therapies. Emtricitabine is also known as cytidine analogue and treats HIV-1 infections by inhibiting reverse transcriptase enzyme, resulting in blockage of viral replication and reduces viral load in patients. Emtricitabine API has high efficacy against HIV and hepatitis B virus [HBV] and provides high oral availability and has long shelf life.

Chemox Pharma is a trusted supplier of Emtricitabine with strict quality assurance and supports all global regulatory documents such as WHO-GMP, FDA, DCGI. Chemox Pharma is a reputed manufacturer of high – quality Active Pharmaceutical Ingredients (APIs) and advanced Intermediates with its multipurpose ultramodern state-of-the-art facility at Dahej Industrial area of Gujarat, India. Chemox Pharma pride on delivering innovative, reliable, and competitively priced solutions, ensuring timely delivery to meet the needs of the global pharmaceutical industry.